Trial Profile
Efficacy of Atazanavir / Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression. Randomized, Open Label Non Inferiority Trial. A Phase 3 Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Feb 2024
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary) ; Nucleoside reverse transcriptase inhibitors; Ritonavir
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms MODAt
- 04 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 17 Mar 2012 New source identified and integrated (European Clinical Trials Database: EudraCT2010-020442-10).